The CO2 regulator’s main function is to control gas flow to levels suitable for endoscopy. Tubing connects a CO2 source, such as a wall-mounted CO2 outlet (in endoscopy suites with a medical gas pipeline) or a transportable CO2 cylinder, to the CO2 regulator.
Gas insufflation is necessary during digestive endoscopy treatments to enable endoscope advancement and adequate mucosa inspection.
The most frequent gas utilised in normal endoscopic settings is room air; however, because air takes a while to reabsorb, subsequent intestinal distension frequently results in abdominal discomfort. Consequently, the use of carbon dioxide (CO2) rather than air is growing.
In reality, it is generally known that because CO2 is absorbed from the gut faster than air and is then exhaled through the lungs, it causes less gastrointestinal discomfort.
Several investigations showed that during colonoscopy, endoscopic retrograde cholangiopancreatography (ERCP), and enteroscopy, CO2 insufflation causes less gastrointestinal discomfort than air.
The global endoscopic co2 regulator market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2022 to 2030.
Three manufacturers in the United States, namely Medivators Inc (Minneapolis, Minn), Bracco Diagnostics Inc (Monroe Township, NJ), and Olympus America Inc (Center Valley, Pa), offer CO2 regulators for sale on the open market.
These CO2 regulators are all lightweight, portable devices that fit readily into typical endoscopic workstations. All of them have the ability to connect to a wall-mounted CO2 source or a portable CO2 cylinder. Various flow rate settings are available on the CO2 regulators.
© Copyright 2017-2023. Mobility Foresights. All Rights Reserved.